2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow GHD: new trials by email Literature Review of GHD trials Research Report on GHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency GenSci004, Genotropin - GHD | Phase 3 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 162 | 2023-12-01 | 2023-09-11 |
| A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency PEG-somatropin - GHD | Phase 3 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 180 | 2023-12-01 | 2023-09-11 |
Bone Diseases (2) · Bone Diseases, Developmental (2) · Bone Diseases, Endocrine (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Dwarfism (2) · Endocrine System Diseases (2) · Hypopituitarism (2) · Hypothalamic Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Pituitary Diseases (2)
Changchun GeneScience Pharmaceutical Co., Ltd. (2)
United States (1)
Bradley Miller (1) · Lawrence Silverman, MD (1)